Literature DB >> 2712544

Interaction of FCE 22101 with penicillin-binding proteins of Staphylococcus aureus.

E A Tonin1, R Fontana.   

Abstract

FCE 22101 is a new penem characterized by a broad spectrum of activity which includes activity against methicillin-resistant strains of Staphylococcus aureus. The interaction of FCE 22101 with penicillin-binding protein 2a of a methicillin-resistant S. aureus strain has been investigated in the present study. In competition experiments, the penem showed a very low affinity for this protein, and a concentration more than 4 times the MIC was required for penicillin-binding protein 2a saturation. When the classical competitive procedure was modified by increasing the time of incubation of either membranes or growing cells with FCE 22101, the antibiotic showed a much higher affinity for penicillin-binding protein 2a and saturated the protein at a concentration close to the MIC, with slow kinetics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712544      PMCID: PMC171435          DOI: 10.1128/AAC.33.1.120

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Susceptibility of anaerobic bacteria to FCE 22101.

Authors:  C E Nord; A Lindmark; I Person
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

2.  Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus.

Authors:  L Rossi; E Tonin; Y R Cheng; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

3.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

4.  Beta-lactam-specific resistant mutants of Staphylococcus aureus.

Authors:  E Tonin; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Synthesis of peptidoglycan in vivo in methicillin-resistant Staphylococcus aureus.

Authors:  A W Wyke; J B Ward; M V Hayes
Journal:  Eur J Biochem       Date:  1982-10

6.  Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.

Authors:  R Wise; J M Andrews; G Danks
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

7.  Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a.

Authors:  H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

8.  A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus.

Authors:  A W Wyke; J B Ward; M V Hayes; N A Curtis
Journal:  Eur J Biochem       Date:  1981-10

9.  Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics.

Authors:  N H Georgopapadakou; S A Smith; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.

Authors:  G Franceschi; M Foglio; M Alpegiani; C Battistini; A Bedeschi; E Perrone; F Zarini; F Arcamone; C Della Bruna; A Sanfilippo
Journal:  J Antibiot (Tokyo)       Date:  1983-07       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.